Abstract
ObjectivesAssessment of disease activity is one of the major difficulties in patients with TAK during follow-up. To date, no biomarker is universally accepted to be a surrogate for active disease...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
